These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1786307)

  • 1. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
    Jantzen JP; Erdmann K; Kleemann PP
    Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
    Sorosky JI; Ingardia CJ; Botti JJ
    Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

  • 7. [New findings and experiences in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 10. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
    López JR; Medina P; Alamo L
    Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
    Free CW; Jaimon MP
    N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
    Quinlan JG; Wedel DJ; Iaizzo PA
    Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment for malignant hyperthermia today.
    Krivosic-Horber R
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):255-9. PubMed ID: 3176862
    [No Abstract]   [Full Text] [Related]  

  • 16. Current understanding of malignant hyperthermia: genesis, prevention, and treatment.
    Katz DN
    CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients].
    Mauritz W; Hackl W; Sporn P; Steinbereithner K
    Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia: an OR emergency!
    Plast Surg Nurs; 2000; 20(4):222-6. PubMed ID: 12025057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.